Dr. Eric M. Shrier, DO

Dr. Shrier practices at Best Women's Medical Care, PC in Brooklyn, New York.

Dr. Shrier's NPI, 1720062037, was assigned on November 30, 2005. Dr. Shrier graduated from Rowan University School of Osteopathic Medicine in 1998. Dr. Shrier holds New York license 219455-1.

Dr. Shrier's primary practice is Best Women's Medical Care, PC, at 142 Joralemon St, Brooklyn, NY 11201 in Kings County. The practice phone is (718) 875-4848.

Dr. Shrier's primary practice is Best Women's Medical Care, PC in Brooklyn, New York. Dr. Shrier is also affiliated with University Hospital at Downstate. The medical group on file is Downstate Health Physicians. Dmand AI also links Dr. Shrier to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrier practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Shrier's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Shrier is licensed in New York.

CMS data shows 7,326 Medicare services from Dr. Shrier across 19 procedure codes in 2024, for 408 Medicare patients. Medicare paid $573,635 for them. Every service was in an office.

CMS counts 408 Medicare patients who saw Dr. Shrier in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrier's median patient age at 68, with 66% women.

In 2024, Dr. Shrier wrote 1,717 Medicare Part D claims for 293 patients. 58% of them were for generic drugs. CMS names the drug for 1,592 of them, across 21 drugs with 11 or more claims each, at $494,811 in total drug cost. In 2023, CMS named 1,736 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Shrier for performance year 2024, reported through an alternative payment model (APM). Dr. Shrier accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Shrier to 1 clinical trial. Conditions studied include Retinopathy of Prematurity and Infant, Premature, Diseases. Open Payments lists research payments to Dr. Shrier that name 1 trial.

CMS Open Payments shows 72 general payments to Dr. Shrier from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $714. It also lists 8 research payments totaling $950 in 2019, naming 1 clinical trial.

Dr. Shrier graduated from Rowan University School of Osteopathic Medicine in 1998.